Web
                        Analytics
Stock AVTX - (NASDAQ) | AVALO THERAPEUTICS INC - Latest analysis by - Deepscope

Stock Check  (Updated: 2024-12-21 07:18:07)
*ข้อมูลอัปเดตรายวัน ที่เวลา 07.00 น.*

USD 8.91
Price
-0.17 (-1.87%)
Day Change
Social: 2

AVTX, the overall quality is not good (Quality = 23) and the timing to buy is ...(Sign In to See)...

23

Quality Score

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors 41%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  Social Score 2
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 8.91
  PBV / Sector
4.09 / 1.56
  Earning Per Share 94.42
  PE / Sector
0.10 / 16.11
GREAT
  PEG or PE/Growth / Sector
N/A / 5.60
  Average 1M Daily Value
1.31 M
GREAT
  Average 1W Daily Value
2.53 M
GREAT
Timing Factors 28%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 41%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 52%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
0.00 / 1,632.79
  NPM Average (%) / Sector
-1,098.49 / -6,972.71
  NPM Change Average (%) / Sector
195.92 / -8,753.21
GREAT
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-30.64 / -47.35
  ROA Average (%) / Sector
-111.61 / -75.29
  ROA Change Average (%) / Sector
-17.27 / 739.17
  ROE (%) / Sector
-42.52 / -270.78
  ROE Average (%) / Sector
-144.06 / -19.90
  ROE Change Average (%) / Sector
-117.09 / -1,735.98
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 70%
X
  Dividend (%) / Sector
0.00 / 0.06
  Dividend Average (%) / Sector
24.90 / 10.67
GREAT
  Dividend Change Average (%) / Sector
68.16 / 1,765.28
GREAT
Registration Details
X
  Analyze Date 2024-12-21 07:39:17
  Symbol AVTX
  Name AVALO THERAPEUTICS INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 10.46 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 95.01 / 3,466.05
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Top Related Stocks